For more information, visit our Surgical Oncology Program
Return to Cancer Program Name Search
Title: Clinical Trial of Approaches to Prostate Cancer Surgery
Brief Title: Clinical Trial of Approaches to Prostate Cancer Surgery
Brief Summary: This is a prospective, randomized controlled trial to compare cancer control and
health-related quality of life following pelvic fascia-sparing radical prostatectomy
versus standard radical prostatectomy.
The investigators hypothesize that pelvic fascia-sparing radical prostatectomy will have
similar cancer control (primary outcome) and sexual function outcomes; and significantly
better urinary function, penile shortening/deformity and inguinal hernia risks as
compared to radical prostatectomy.
For info regarding 24-693
please contact Cancer Clinical Trials at 617-975-7403 or
cancerclinicaltrialsinfo@bidmc.harvard.edu
Title: A Phase 3, Randomized Study of Adjuvant Cretostimogene Grenadenorepvec versus Observation for the Treatment of Intermediate Risk Non-Muscle Invasive Bladder Cancer (IR-NMIBC) Following Transurethral Resection of Bladder Tumor (TURBT)
Brief Title: A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT
Brief Summary: This is a Phase 3, open-label, randomized trial designed to evaluate the RFS of TURBT
followed by cretostimogene grenadenorepvec versus TURBT followed by surveillance for the
treatment of participants with IR-NMIBC.
For info regarding 24-247
please contact Cancer Clinical Trials at 617-975-7403 or
cancerclinicaltrialsinfo@bidmc.harvard.edu
Title: An Objective and Subjective Assessment of the Financial Burden of Thyroid Cancer
Brief Title: Financial Burden of Thyroid Cancer
For info regarding 24-004
please contact Cancer Clinical Trials at 617-975-7403 or
cancerclinicaltrialsinfo@bidmc.harvard.edu
Title: Randomized controlled trial assessing transperineal prostate biopsy to reduce infection complications
Brief Title: PReclude Infection EVEnts With No Prophylaxis Transperineal Biopsy 2
Brief Summary: Approximately one million transrectal prostate biopsies are performed annually in the
U.S., and the risk of post- biopsy infection is increasing due to greater antibiotic
resistance of rectal flora. Preliminary data demonstrates that a transperineal
MRI-targeted biopsy approach under local anesthesia compared to the standard practice
transrectal MRI-targeted prostate biopsy has a much lower risk of infection, comparable
pain/discomfort and may improve detection of prostate cancer.
This randomized controlled trial will be the first prospective study to evaluate
in-office transperineal MRI targeted prostate biopsy.
The investigators hypothesize that a transperineal MRI-targeted biopsy approach under
local anesthesia compared to the standard practice transrectal MRI-targeted prostate
biopsy has a much lower risk of infection, comparable pain/discomfort and may improve
detection of prostate cancer.
For info regarding 23-290
please contact Cancer Clinical Trials at 617-975-7403 or
cancerclinicaltrialsinfo@bidmc.harvard.edu
Title: A Phase 1/2a Study of STM-416 Administered Intraoperatively to Patients Undergoing Transurethral Resection of Bladder Tumor (TURBT) for Recurrent High-Grade Papillary Bladder Cancer.
Brief Title: A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
Brief Summary: This is a first-in-human (FIH), Phase 1/2a, multi center, open-label, single treatment,
dose escalation and expansion study designed to determine the safety and tolerability of
STM-416 in patients with bladder cancer.
For info regarding 23-164
please contact Cancer Clinical Trials at 617-975-7403 or
cancerclinicaltrialsinfo@bidmc.harvard.edu
Title: Blue Light Cystoscopy With Cysview® (BLC with Cysview®) Registry
Brief Title: Blue Light Cystoscopy With Cysview® Registry
Brief Summary: Registry study to gather more information on the current use of Blue Light Cystoscopy
with Cysview (BLCC) in urologists' practices.
For info regarding 22-484
please contact Cancer Clinical Trials at 617-975-7403 or
cancerclinicaltrialsinfo@bidmc.harvard.edu
Title: Feasibility and Efficacy of the AveCure Flexible Microwave Ablation Probe for Peripheral Lung Nodules
Brief Title: Avecure Flexible Microwave Ablation Probe For Lung Nodules
Brief Summary: This research study to determine the effectiveness of the AveCure Flexible Microwave
Ablation Probe to destroy cancerous lung nodules up to 3 c m in size.
This research study involves microwave ablation (MWA)
For info regarding 21-412
please contact Cancer Clinical Trials at 617-975-7403 or
cancerclinicaltrialsinfo@bidmc.harvard.edu
Title: Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone: A Prospective Randomized Controlled Trial
Brief Title: Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone
Brief Summary: The purpose of the clinical study is to investigate whether the local delivery of
bisphosphonate as a surgical adjuvant can decrease the chance of a giant cell tumor of
bone coming back to the same location. The hypothesis is that the local administration of
bisphosphonate will decrease the rate of the tumor returning compared to traditional
aggressive surgical removal of the tumor.
For info regarding 21-396
please contact Cancer Clinical Trials at 617-975-7403 or
cancerclinicaltrialsinfo@bidmc.harvard.edu
Title: Variable anatomy & function of the arm's alternate lymphatic pathway
Brief Title: Mapping and Quantifying Lymphatic Drainage of the Arm's Alternate Pathway
Brief Summary: Using indocyanine green (ICG) lymphography and lymphoscintigraphy with SPECT/CT imaging,
the aim is to evaluate the anatomy of the lymphatic system pathway in two separate
populations: healthy female volunteers and women with a history of breast cancer who did
not develop lymphedema.
For info regarding 21-324
please contact Cancer Clinical Trials at 617-975-7403 or
cancerclinicaltrialsinfo@bidmc.harvard.edu
Title: Edrn Prostate MRI Biomarker Study And Reference Set
Brief Title: EDRN Prostate MRI Biomarker Study
Brief Summary: The commercialization of MRI fusion biopsies has resulted in a dramatic increase in the
use of MRI imaging for prostate cancer. How best to use MRI in the initial prostate
biopsy setting given the availability of validated prostate cancer early detection
markers is uncertain.This study will allow investigators to determine if prostate MRI is
superior to validated panel of laboratory biomarkers (e.g. PCA3, PSA and TMPRSS2:ERG) in
the initial biopsy setting.
For info regarding 19-334
please contact Cancer Clinical Trials at 617-975-7403 or
cancerclinicaltrialsinfo@bidmc.harvard.edu
Title: Validating axillary imaging in determining disease burden of advanced axillary disease in Breast cancer
Brief Title: Validating axillary imaging in determining disease burden of advanced axillary disease in Breast can
For info regarding 18-127
please contact Cancer Clinical Trials at 617-975-7403 or
cancerclinicaltrialsinfo@bidmc.harvard.edu
Title: Impact of a Multidisciplinary Clinic in Management of Patients with New Diagnoses of Pancreatic Cancer
Brief Title: MULTIDISCIPLINARY CLINIC IN MANAGEMENT OF PTS W NEW DIAGNOSES OF PANCREATIC CANCER
For info regarding 15-004
please contact Cancer Clinical Trials at 617-975-7403 or
cancerclinicaltrialsinfo@bidmc.harvard.edu
Title: Effectiveness of Open and Robotic Prostatectomy: The PROSTQA-RP2 Cohort Study
Brief Title: Effectiveness of Open and Robotic Prostatectomy
Brief Summary: Prostate cancer is the most common cancer in American men. Surgical removal of the entire
prostate (prostatectomy) is one option among the various ways to treat prostate cancer.
The use of robot assistance for prostatectomy has become common place, but its
effectiveness has not been compared to standard open prostatectomy in trials carried out
at more than one medical institution in which participants are identified and followed
forward in time. Robot assisted and standard open prostatectomy health related quality of
life (HRQOL) outcomes have not been compared in a prospective, multi-centered study.
Prostatectomy can have side effects that can change with time. This research study seeks
to determine how common and how long-lasting such side effects are; to find out what
features of individual men's cancers and what features of the treatments affect those
side effects. This study also seeks to identify factors that affect the quality of
prostate cancer care by looking at how satisfied men are with their prostate cancer care.
Through these findings, this study aims to allow treatment side effects to be anticipated
more accurately for individual patients, and to provide a means for determining the
quality of prostate care.
For info regarding 10-155
please contact Cancer Clinical Trials at 617-975-7403 or
cancerclinicaltrialsinfo@bidmc.harvard.edu
Title: Canary Prostate Active Surveillance Study
Brief Title: Canary Prostate Active Surveillance Study
For info regarding 10-123
please contact Cancer Clinical Trials at 617-975-7403 or
cancerclinicaltrialsinfo@bidmc.harvard.edu